Literature DB >> 17008551

The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration.

Lara Rossi1, Rossella Manfredini, Francesco Bertolini, Davide Ferrari, Miriam Fogli, Roberta Zini, Simona Salati, Valentina Salvestrini, Sara Gulinelli, Elena Adinolfi, Sergio Ferrari, Francesco Di Virgilio, Michele Baccarani, Roberto M Lemoli.   

Abstract

Homing and engraftment of hematopoietic stem cells (HSCs) to the bone marrow (BM) involve a complex interplay between chemokines, cytokines, and nonpeptide molecules. Extracellular nucleotides and their cognate P2 receptors are emerging as key factors of inflammation and related chemotactic responses. In this study, we investigated the activity of extracellular adenosine triphosphate (ATP) and uridine triphosphate (UTP) on CXCL12-stimulated CD34+ HSC chemotaxis. In vitro, UTP significantly improved HSC migration, inhibited cell membrane CXCR4 down-regulation by migrating CD34+ cells, and increased cell adhesion to fibronectin. In vivo, preincubation with UTP significantly enhanced the BM homing efficiency of human CD34+ cells in immunodeficient mice. Pertussis toxin blocked CXCL12- and UTP-dependent chemotactic responses, suggesting that G-protein alpha-subunits (Galphai) may provide a converging signal for CXCR4- and P2Y-activated transduction pathways. In addition, gene expression profiling of UTP- and CXCL12-treated CD34+ cells and in vitro inhibition assays demonstrated that Rho guanosine 5'-triphosphatase (GTPase) Rac2 and downstream effectors Rho GTPase-activated kinases 1 and 2 (ROCK1/2) are involved in UTP-promoted/CXCL12-dependent HSC migration. Our data suggest that UTP may physiologically modulate the homing of HSCs to the BM, in concert with CXCL12, via the activation of converging signaling pathways between CXCR4 and P2Y receptors, involving Galphai proteins and RhoGTPases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17008551     DOI: 10.1182/blood-2006-01-035634

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  52 in total

Review 1.  Perspectives of purinergic signaling in stem cell differentiation and tissue regeneration.

Authors:  Talita Glaser; Angélica Regina Cappellari; Micheli Mainardi Pillat; Isabele Cristiana Iser; Márcia Rosângela Wink; Ana Maria Oliveira Battastini; Henning Ulrich
Journal:  Purinergic Signal       Date:  2011-12-06       Impact factor: 3.765

Review 2.  New insights regarding the regulation of chemotaxis by nucleotides, adenosine, and their receptors.

Authors:  Ross Corriden; Paul A Insel
Journal:  Purinergic Signal       Date:  2012-04-15       Impact factor: 3.765

Review 3.  Interaction of P2 purinergic receptors with cellular macromolecules.

Authors:  Laszlo Köles; Zoltan Gerevich; João Felipe Oliveira; Zoltan Sandor Zadori; Kerstin Wirkner; Peter Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-19       Impact factor: 3.000

4.  The nucleotide sugar UDP-glucose mobilizes long-term repopulating primitive hematopoietic cells.

Authors:  Sungho Kook; Joonseok Cho; Sean Bong Lee; Byeong-Chel Lee
Journal:  J Clin Invest       Date:  2013-07-25       Impact factor: 14.808

Review 5.  Purinergic signalling in the musculoskeletal system.

Authors:  Geoffrey Burnstock; Timothy R Arnett; Isabel R Orriss
Journal:  Purinergic Signal       Date:  2013-08-14       Impact factor: 3.765

Review 6.  Expression and function of P2 receptors in hematopoietic stem and progenitor cells.

Authors:  Wenli Feng; Lina Wang; Guoguang Zheng
Journal:  Stem Cell Investig       Date:  2015-07-30

7.  Concomitant activation of P2Y(2) and P2Y(6) receptors on monocytes is required for TLR1/2-induced neutrophil migration by regulating IL-8 secretion.

Authors:  Fethia Ben Yebdri; Filip Kukulski; Alain Tremblay; Jean Sévigny
Journal:  Eur J Immunol       Date:  2009-10       Impact factor: 5.532

Review 8.  Purinergic signaling in embryonic and stem cell development.

Authors:  Geoffrey Burnstock; Henning Ulrich
Journal:  Cell Mol Life Sci       Date:  2011-01-08       Impact factor: 9.261

9.  The Potentials and Pitfalls of Using Adult Stem Cells in Cancer Treatment.

Authors:  Mrinal K Das; Taral R Lunavat; Hrvoje Miletic; Jubayer A Hossain
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages.

Authors:  Marilena Ciciarello; Roberta Zini; Lara Rossi; Valentina Salvestrini; Davide Ferrari; Rossella Manfredini; Roberto M Lemoli
Journal:  Stem Cells Dev       Date:  2012-12-21       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.